Under oral administration, the occurrence rate of adverse events (AE) significantly decreases in patients with a medication duration exceeding 360 days compared to subcutaneous injection (reducing from 5% to 2%)
In practice, you would round to 8 units (0.24 mg) or draw to the closest line you can identify
The FDA determined the withdrawal was not for reasons of safety or effectiveness it was commercial
That said, staying on semaglutide is a decision you should make with your provider based on your health goals, how you respond to treatment, and whether the benefits continue to outweigh any side effects
J Investig Med High Impact Case Rep
As expected, the most common side effects were nausea, change in bowel function and headache